Dow Jones

38 711,29

0,36%

DAX

Inscrivez-vous pour interagir sur nos forums actifs pour discuter avec des investisseurs aux idées similaires.

S'inscrire

Accueil
Investir
Actions
Etats-Unis
NASDAQ
Entellus Medical, Inc. (delisted) (ENTL)
Entellus Medical, Inc. (delisted) (ENTL) Actualités

ENTL

ENTELLUS MEDICAL INC (ENTL)

Entellus Medical, Inc. (delisted)

De:

Actualités Réglementées

Mots clefs:

Trier par:

Actualités Non-réglementées

Showing the most relevant articles for your search:NASDAQ:ENTL

1 2 3 4 Suivant >>

Date	Heure	Source	Titre	Symbole	Société
01/02/2019	23h30	Edgar (US Regulatory)	Statement of Ownership (sc 13g)	NASDAQ:ENTL	Entellus Medical, Inc. (delisted)
28/06/2018	22h30	GlobeNewswire Inc.	Multi-Center Market Research Confirms Nasal Valve Collapse as a Contributor for Most Nasal Obstruction Sufferers	NASDAQ:ENTL	Entellus Medical, Inc. (delisted)
19/06/2018	14h00	GlobeNewswire Inc.	Entellus Medical announces publication of the 1-year results of a randomized controlled trial comparing balloon dilation with...	NASDAQ:ENTL	Entellus Medical, Inc. (delisted)
31/05/2018	14h00	GlobeNewswire Inc.	Entellus Medical Announces Multi-Center Clinical Study Publication Confirming Nasal Obstruction Symptom Improvement from LATE...	NASDAQ:ENTL	Entellus Medical, Inc. (delisted)
12/03/2018	22h18	Edgar (US Regulatory)	Termination of Registration of a Class of Security Under Section 12(b) (15-12b)	NASDAQ:ENTL	Entellus Medical, Inc. (delisted)
08/03/2018	22h27	Edgar (US Regulatory)	Amended Statement of Beneficial Ownership (sc 13d/a)	NASDAQ:ENTL	Entellus Medical, Inc. (delisted)
07/03/2018	12h02	Edgar (US Regulatory)	Notice of Effectiveness (effect)	NASDAQ:ENTL	Entellus Medical, Inc. (delisted)
01/03/2018	22h10	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:ENTL	Entellus Medical, Inc. (delisted)
28/02/2018	21h50	Edgar (US Regulatory)	Statement of Beneficial Ownership (sc 13d)	NASDAQ:ENTL	Entellus Medical, Inc. (delisted)
28/02/2018	19h37	Edgar (US Regulatory)	Post-effective Amendment to an S-8 Filing (s-8 Pos)	NASDAQ:ENTL	Entellus Medical, Inc. (delisted)
28/02/2018	19h18	Edgar (US Regulatory)	Post-effective Amendment to Registration Statement (pos Am)	NASDAQ:ENTL	Entellus Medical, Inc. (delisted)
28/02/2018	15h16	Edgar (US Regulatory)	(25-NSE)	NASDAQ:ENTL	Entellus Medical, Inc. (delisted)
28/02/2018	14h55	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:ENTL	Entellus Medical, Inc. (delisted)
15/02/2018	23h31	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	NASDAQ:ENTL	Entellus Medical, Inc. (delisted)
24/01/2018	12h11	Edgar (US Regulatory)	Proxy Statement - Merger or Acquistion (definitive) (defm14a)	NASDAQ:ENTL	Entellus Medical, Inc. (delisted)
08/01/2018	12h13	Edgar (US Regulatory)	Proxy Statement - Merger or Acquistion (preliminary) (prem14a)	NASDAQ:ENTL	Entellus Medical, Inc. (delisted)
04/01/2018	15h02	Edgar (US Regulatory)	Additional Proxy Soliciting Materials (definitive) (defa14a)	NASDAQ:ENTL	Entellus Medical, Inc. (delisted)
18/12/2017	22h56	Edgar (US Regulatory)	Initial Statement of Beneficial Ownership (3)	NASDAQ:ENTL	Entellus Medical, Inc. (delisted)
08/12/2017	15h30	PR Newswire (US)	ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of Entellus Medical, Inc.	NASDAQ:ENTL	Entellus Medical, Inc. (delisted)
07/12/2017	15h15	Dow Jones News	Stryker to Buy Entellus Medical For $662 Million	NASDAQ:ENTL	Entellus Medical, Inc. (delisted)
07/12/2017	14h15	GlobeNewswire Inc.	Entellus Medical Announces Definitive Agreement to be Acquired by Stryker Corporation for a Purchase Price of $24.00 Per Shar...	NASDAQ:ENTL	Entellus Medical, Inc. (delisted)
14/11/2017	22h05	GlobeNewswire Inc.	Entellus Medical to Participate in Upcoming Investor Conferences	NASDAQ:ENTL	Entellus Medical, Inc. (delisted)
13/11/2017	11h30	GlobeNewswire Inc.	Anthem Inc. Issues Positive Coverage Decision for Balloon Sinus Dilation	NASDAQ:ENTL	Entellus Medical, Inc. (delisted)
03/11/2017	21h06	Edgar (US Regulatory)	Quarterly Report (10-q)	NASDAQ:ENTL	Entellus Medical, Inc. (delisted)
01/11/2017	21h05	GlobeNewswire Inc.	Entellus Medical Announces Third Quarter 2017 Financial Results	NASDAQ:ENTL	Entellus Medical, Inc. (delisted)
30/10/2017	13h30	GlobeNewswire Inc.	Entellus Announces Long-Term Data Confirming the Durable Relief of Nasal Obstruction Symptoms with Latera® from Spirox®	NASDAQ:ENTL	Entellus Medical, Inc. (delisted)
18/10/2017	22h05	GlobeNewswire Inc.	Entellus Medical to Report Third Quarter 2017 Financial Results November 1, 2017	NASDAQ:ENTL	Entellus Medical, Inc. (delisted)
04/10/2017	23h30	Edgar (US Regulatory)	Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)	NASDAQ:ENTL	Entellus Medical, Inc. (delisted)
25/09/2017	22h43	Edgar (US Regulatory)	Securities Registration: Employee Benefit Plan (s-8)	NASDAQ:ENTL	Entellus Medical, Inc. (delisted)
25/09/2017	22h31	Edgar (US Regulatory)	Securities Registration Statement (simplified Form) (s-3)	NASDAQ:ENTL	Entellus Medical, Inc. (delisted)